Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
14.49
-0.53 (-3.53%)
At close: Jun 18, 2026, 4:00 PM EDT
14.50
+0.01 (0.07%)
After-hours: Jun 18, 2026, 7:59 PM EDT
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $785.15 million as of June 18, 2026. Its market cap has increased by 2,647.38% in one year.
Market Cap
785.15M
Enterprise Value
296.57M
1-Year Change
2,647.38%
Ranking
Category
Stock Price
$14.49
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $785.15M, a decrease of -39.56%. That is a compound annual growth rate of -8.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 785.15M | 55.03% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 841.41M |
| Olema Pharmaceuticals | 830.67M |
| Solid Biosciences | 820.09M |
| Geron | 808.32M |
| Annexon | 802.83M |
| Alto Neuroscience | 798.04M |
| Design Therapeutics | 776.96M |
| Avalo Therapeutics | 772.71M |